The Animal Biotechnology Market is being driven by Increasing growth strategies of market players
The Animal Biotechnology Market is expected to grow at a CAGR of 3.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 4465.1 million. In the animal health industry, biotechnology solutions hold significant value due to their potential applications in addressing various diseases afflicting livestock and companion animals. Diseases such as osteoarthritis, leptospirosis, Foot-and-Mouth Disease (FMD), salmonella, swine fever, avian influenza, and Bovine Respiratory Disease (BRD) pose significant challenges, leading to increased demand for effective drugs, vaccines, and diagnostic tests. For instance, osteoarthritis, a common condition in cats and dogs, affects over 60% of cats above six years and 90% above twelve. Current treatments for feline osteoarthritis pain are often inadequate due to limited long-term safety and efficacy. The growing prevalence of animal diseases necessitates continuous innovation and investment in animal biotechnology products.
Get more information on Animal Biotechnology Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
252 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.3% |
Market growth 2025-2029 |
USD 4465.1 million |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
3.1 |
Key countries |
US, Germany, Canada, China, UK, Brazil, France, Japan, Australia, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
Animal biotechnology encompasses various applications of genetic engineering, molecular biology, and reproductive technologies in the field of animal agriculture and health. It focuses on enhancing animal health, improving productivity in animal-based goods and derived products, and developing biotech solutions for cancer treatment, pharmaceutical development, and public health systems. Animal feed sector benefits from this technology through disease resistance, diagnostic tests, and vaccine innovation. Biotech research in animal health includes genetically modified animals, cloning techniques, and therapeutic proteins for preventative care and disease treatment. Animal welfare is also addressed through health management and protein synthesis. Zoonotic diseases and bovine spongiform encephalopathy are targeted through diagnostic tests and disease resistance. Biotech products play a crucial role in animal agriculture efficiency and animal health, ensuring the production of safe and high-quality animal-derived products.
The animal biotechnology market is a significant segment of the larger global biotechnology industry, encompassing companies and research institutions specializing in genetic engineering, reproductive technologies, and animal health. These advancements contribute to the production of animal-based goods and animal-derived products. The global healthcare market, which includes the revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is projected to expand substantially. Factors driving this growth include the increasing global population aging, with the proportion of individuals over 60 years expected to reach nearly one-quarter in the US by 2050 and Europe by 2030. This demographic shift will fuel demand for improved animal health and productivity, as well as the development of new animal-derived products and biotechnological applications.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted